BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 8704180)

  • 1. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlations.
    Mansoor A; Stevenson MS; Li RZ; Frekko K; Weiss W; Ahmad M; Khan AH; Mushtaq S; Saleem M; Raffeld M; Kingma DW; Jaffe ES
    Hum Pathol; 1997 Mar; 28(3):283-8. PubMed ID: 9042791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
    Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
    Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.
    Sandvej K; Peh SC; Andresen BS; Pallesen G
    Blood; 1994 Dec; 84(12):4053-60. PubMed ID: 7994023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J; Schirrmacher V; Mosier D
    Int J Cancer; 1995 May; 61(3):363-9. PubMed ID: 7537255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions within the epstein-barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's disease.
    Santón A; Bellas C
    Leuk Lymphoma; 2001 Jan; 40(3-4):235-42. PubMed ID: 11426545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.